- Home
- GELS vs CRIS Comparison
GELS vs CRIS Comparison
Compare GELS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GELS
- CRIS
- Stock Information
- Founded
- GELS 2018
- CRIS 2000
- Country
- GELS Australia
- CRIS United States
- Employees
- GELS N/A
- CRIS N/A
- Industry
- GELS
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GELS
- CRIS Health Care
- Exchange
- GELS NYSE
- CRIS Nasdaq
- Market Cap
- GELS 15.8M
- CRIS 13.5M
- IPO Year
- GELS 2024
- CRIS 2000
- Fundamental
- Price
- GELS $1.51
- CRIS $1.96
- Analyst Decision
- GELS
- CRIS Strong Buy
- Analyst Count
- GELS 0
- CRIS 3
- Target Price
- GELS N/A
- CRIS $21.00
- AVG Volume (30 Days)
- GELS 4.7M
- CRIS 106.4K
- Earning Date
- GELS 02-15-2025
- CRIS 05-06-2025
- Dividend Yield
- GELS N/A
- CRIS N/A
- EPS Growth
- GELS N/A
- CRIS N/A
- EPS
- GELS N/A
- CRIS N/A
- Revenue
- GELS $95,618.00
- CRIS $11,202,000.00
- Revenue This Year
- GELS N/A
- CRIS $2.62
- Revenue Next Year
- GELS N/A
- CRIS $9.84
- P/E Ratio
- GELS N/A
- CRIS N/A
- Revenue Growth
- GELS N/A
- CRIS 14.17
- 52 Week Low
- GELS $0.77
- CRIS $1.02
- 52 Week High
- GELS $5.50
- CRIS $16.93
- Technical
- Relative Strength Index (RSI)
- GELS N/A
- CRIS 52.24
- Support Level
- GELS N/A
- CRIS $1.06
- Resistance Level
- GELS N/A
- CRIS $2.45
- Average True Range (ATR)
- GELS 0.00
- CRIS 0.30
- MACD
- GELS 0.00
- CRIS 0.02
- Stochastic Oscillator
- GELS 0.00
- CRIS 36.19
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.